Showing results (21-30 of 79) with videos related to
Sort By:
Pageof 8
Stroke|July 1, 2006
Recurrent extracranial carotid artery vasospasms: report of 2 casesWibke G Janzarik, Peter A Ringleb, Matthias Reinhard, et al.Journal of the Neurological Sciences|December 28, 2020
Diagnosis of multiple sclerosis in times of MOG and AQP4 autoantibody testing - A monocentric studyJuliane Weber, Nora Bernsdorff, Tilman Robinson, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|August 9, 2020
COVID-19 pneumonia in a multiple sclerosis patient with severe lymphopenia due to recent cladribine treatmentRick Dersch, Thomas Wehrum, Sebastian Fähndrich, et al.Fluids and Barriers of the CNS|February 8, 2017
The MRZ reaction in primary progressive multiple sclerosisTilman Hottenrott, Rick Dersch, Benjamin Berger, et al.Journal of Neuroimmunology|January 19, 2007
Specific antibody index in cerebrospinal fluid from patients with central and peripheral paraneoplastic neurological syndromesOliver Stich, Sven Jarius, Barbara Kleer, et al.Journal of the Neurological Sciences|April 1, 2015
"Non-classical" paraneoplastic neurological syndromes associated with well-characterized antineuronal antibodies as compared to "classical" syndromes - More frequent than expectedBenjamin Berger, Patricia Bischler, Rick Dersch, et al.Journal of the Neurological Sciences|September 23, 2016
Prevalence of anti-SOX1 reactivity in various neurological disordersBenjamin Berger, Rick Dersch, Elisabeth Ruthardt, et al.AJNR. American Journal of Neuroradiology|February 15, 2005
Solitary spinal artery aneurysms as a rare source of spinal subarachnoid hemorrhage: potential etiology and treatment strategyAnsgar Berlis, Kai-Michael Scheufler, Christian Schmahl, et al.Multiple Sclerosis and Related Disorders|January 30, 2025
McDonald criteria application by German neurologists suggests a need for further trainingJohannes Heinemann, Dimitar Yankov, Andrew J Solomon, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|August 25, 2014
Massive exacerbation of multiple sclerosis after withdrawal and early restart of treatment with natalizumabLena-Alexandra Beume, Rick Dersch, Hannah Fuhrer, et al.Pageof 8